Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine

Amoolya Kandettu; Divya Adiga; Vasudha Devi; Padmanaban S. Suresh; Sanjiban Chakrabarty; Raghu Radhakrishnan; Shama Prasada Kabekkodu

doi:10.1016/j.gendis.2021.12.026

您当前的位置：

首页 >

文章列表页 >

Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine

Review article | 更新时间：2022-11-09

- Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine
- Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine
- Genes & Diseases 2022年9卷第6期
- 作者机构：
  
  1. Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka,India,576104
  2. Department of Pharmacology, Centre for Cardiovascular Pharmacology, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal Campus, Manipal, Karnataka,India,576104
  3. School of Biotechnology, National Institute of Technology, Calicut, Kerala,India,673601
  4. Center for DNA Repair and Genome Stability (CDRGS), Manipal Academy of Higher Education, Manipal, Karnataka,India,576104
  5. Department of Oral Pathology, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, Karnataka,India,576104
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.12.026
  中图分类号：
- 纸质出版日期：2022，
  
  网络出版日期：2022-11-1，
扫描看全文
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine[J]. Genes & Diseases, 2022,9(6).

Amoolya Kandettu, Divya Adiga, Vasudha Devi, et al. Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine[J]. Genes & Diseases, 2022,9(6).
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine[J]. Genes & Diseases, 2022,9(6). DOI： 10.1016/j.gendis.2021.12.026.

Amoolya Kandettu, Divya Adiga, Vasudha Devi, et al. Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine[J]. Genes & Diseases, 2022,9(6). DOI： 10.1016/j.gendis.2021.12.026.

摘要

Abstract

Ovarian cancer (OC) is one of the most common and fatal types of gynecological cancer. OC is usually detected at the advanced stages of the disease

making it highly lethal. miRNAs are single-stranded

small non-coding RNAs with an approximate size ranging around 22 nt. Interestingly

a considerable proportion of miRNAs are organized in clusters with miRNA genes placed adjacent to one another

getting transcribed together to result in miRNA clusters (MCs). MCs comprise two or more miRNAs that follow the same orientation during transcription. Abnormal expression of the miRNA cluster has been identified as one of the key drivers in OC. MC exists both as tumor-suppressive and oncogenic clusters and has a significant role in OC pathogenesis by facilitating cancer cells to acquire various hallmarks. The present review summarizes the regulation and biological function of MCs in OC. The review also highlights the utility of abnormally expressed MCs in the clinical management of OC.

关键词

Keywords

DiagnosisDrug resistancemiRNA clustersOvarian cancerPrognosisRegulation

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Development of a tRNA-derived small RNA diagnostic and prognostic signature in liver cancer

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer

The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities

Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer

Mechanism of PARP inhibitor resistance and potential overcoming strategies